Gastric Inhibitory Polypeptide (6-30) amide (human)
目录号 : GA21895The porcine homolog of gastric inhibitory polypeptide (6-30) amide (human) also known as glucose-dependent insulinotropic polypeptide (6-30) amide (human) has been found to antagonize the induction of cAMP production of gastric inhibitory polypeptide (human) (GIP (human)) (H-5645) in vitro. In competitive binding studies it has been shown to exhibit receptor binding affinity equivalent to the gastric inhibitory polypeptide (human) (IC?? = 3.08 ± 0.57 nM).
Cas No.:1139691-72-7
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
The porcine homolog of gastric inhibitory polypeptide (6-30) amide (human) also known as glucose-dependent insulinotropic polypeptide (6-30) amide (human) has been found to antagonize the induction of cAMP production of gastric inhibitory polypeptide (
Cas No. | 1139691-72-7 | SDF | |
分子式 | C139H209N35O38S | 分子量 | 3010.47 |
溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 0.3322 mL | 1.6609 mL | 3.3217 mL |
5 mM | 0.0664 mL | 0.3322 mL | 0.6643 mL |
10 mM | 0.0332 mL | 0.1661 mL | 0.3322 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。